rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Ronald D. Green

Director

Company insider

Files Form 4 as: Director, Neogen.

In numbers

Trades disclosed
38
Buys
1
Sells
1
Bought
$34K
Sold
$297K
Companies
1
Companies where not an officer
1
First trade
1 Oct 2015
Last trade
1 Oct 2026
Last filed
2 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
NEOG NeogenDirector · Diagnostics & Labs · last 1 Oct 20261 buy · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Oct 2026filed 2 Oct 2026NEOG NeogenDiagnostics & LabsSEC FORM 4 Code A$120K9,804 at $12.24filing
1 Oct 2026filed 2 Oct 2026NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—20,558 at $0.00filing
27 Oct 2025filed 29 Oct 2025NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code M$11K1,777 at $6.19filing
27 Oct 2025filed 29 Oct 2025NEOG NeogenDiagnostics & LabsSEC FORM 4 Code M$11K1,777 at $6.19filing
23 Oct 2025filed 27 Oct 2025NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—50,814 at $0.00filing
23 Oct 2025filed 27 Oct 2025NEOG NeogenDiagnostics & LabsSEC FORM 4 Code A$120K19,769 at $6.07filing
7 Oct 2025filed 9 Oct 2025NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code M$12K2,071 at $5.63filing
7 Oct 2025filed 9 Oct 2025NEOG NeogenDiagnostics & LabsSEC FORM 4 Code M$12K2,071 at $5.63filing
28 Oct 2024filed 29 Oct 2024NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code M$25K1,776 at $13.81filing
28 Oct 2024filed 29 Oct 2024NEOG NeogenDiagnostics & LabsSEC FORM 4 Code M$25K1,776 at $13.81filing
24 Oct 2024filed 28 Oct 2024NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—18,653 at $0.00filing
24 Oct 2024filed 28 Oct 2024NEOG NeogenDiagnostics & LabsSEC FORM 4 Code A$82K6,075 at $13.58filing
7 Oct 2024filed 9 Oct 2024NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code M$31K2,070 at $15.07filing
7 Oct 2024filed 9 Oct 2024NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code M$3,514236 at $14.89filing
7 Oct 2024filed 9 Oct 2024NEOG NeogenDiagnostics & LabsSEC FORM 4 Code M$31K2,070 at $15.07filing
7 Oct 2024filed 9 Oct 2024NEOG NeogenDiagnostics & LabsSEC FORM 4 Code M$3,514236 at $14.89filing
29 Aug 2024filed 3 Sep 2024NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—4,446 at $0.00filing
29 Aug 2024filed 3 Sep 2024NEOG NeogenDiagnostics & LabsSEC FORM 4 Code M$69K4,446 at $15.47filing
29 Aug 2024filed 3 Sep 2024NEOG NeogenDiagnostics & LabsSEC FORM 4 Code F$69K4,019 at $17.12filing
26 Oct 2023filed 31 Oct 2023NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—13,716 at $0.00filing

News

Head-To-Head Analysis: Delcath Systems (NASDAQ:DCTH) & Neogen (NASDAQ:NEOG)NEOG · themarketsdaily.com · 18 Oct 2026

0 headlines in the last 90 days name Ronald D. Green; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Mikheal NassifCEO · CEO at Neogen, filing Form 4 there in the last year
James C. BorelDirector · Director at Neogen, filing Form 4 there in the last year
Avi PelossofDirector · Director at Neogen, filing Form 4 there in the last year
Andrea F. WainerDirector · Director at Neogen, filing Form 4 there in the last year
Jeffrey D. CapelloDirector · Director at Neogen, filing Form 4 there in the last year